Prevention of Hb Bart’s (γ4) Disease Associated with the – –THAI α0-Thalassemia Deletion in Mainland China

Abstract α-Thalassemia (α-thal) is a common inherited disease in southern China. The severest form is Hb Bart’s (γ4) disease, in which the affected fetuses almost always die in utero or shortly after birth, and the mothers are at high risk for severe morbidity. The most common type of α0-thalassemia (α0-thal) in southern China is Southeast Asian (– –SEA) deletion. Occasionally, Hb Bart’s disease, caused by a compound heterozygosity for the – –SEA and – –THAI α0-thal deletions, can also be encountered. In this study, we report our experience with the prevention of Hb Bart’s disease associated with the – –THAI α0-thal deletion. A total of 385 couples at risk for Hb Bart’s disease, including seven who tested positive for the – –SEA deletion in one partner and the – –THAI deletion in the other, were found. Different prenatal procedures were offered, depending on the gestational age at presentation. Sixty-six affected fetuses were diagnosed prenatally; among these, two cases of Hb Bart’s disease were compound heterozygotes for the – –SEA and – –THAI deletions. All affected pregnancies were terminated in time. We also presented a diagnostic protocol for identification of α0-thal trait that can reduce the number of samples for detection of the – –THAI deletion.

[1]  Xiao-Xian Tian,et al.  Sonographic Markers of Fetal α‐Thalassemia Major , 2015, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[2]  Dongzhi Li,et al.  Newborn screening for α-thalassaemia by a capillary electrophoresis method , 2012, Journal of medical screening.

[3]  Maxine Sun,et al.  Molecular epidemiological survey of haemoglobinopathies in the Guangxi Zhuang Autonomous Region of southern China , 2010, Clinical genetics.

[4]  C. Liao,et al.  Prenatal diagnosis of hemoglobin Bart's disease caused by co‐inheritance of two different α0‐thalassemia defects in China , 2009, Prenatal diagnosis.

[5]  Dongzhi Li,et al.  A Survey of Pregnancies with Hb Bart's Disease in Mainland China , 2009, Hemoglobin.

[6]  C. Liao,et al.  Nonimmune Hydrops Fetalis Diagnosed during the Second Half of Pregnancy in Southern China , 2007, Fetal Diagnosis and Therapy.

[7]  C. Liao,et al.  Prenatal Control of Hb Bart's Disease in Southern China , 2007, Hemoglobin.

[8]  V. Chan,et al.  A new strategy for prenatal diagnosis of homozygous α0‐thalassemia , 2006 .

[9]  G. Luo,et al.  The prevalence and spectrum of α and β thalassaemia in Guangdong Province: implications for the future health burden and population screening , 2004, Journal of Clinical Pathology.

[10]  J. Clegg,et al.  Rapid detection of α‐thalassaemia deletions and α‐globin gene triplication by multiplex polymerase chain reactions , 2000, British journal of haematology.

[11]  D. Higgs,et al.  The −−THAI and −−FIL determinants of α thalassemia in Taiwan , 1999, American journal of hematology.

[12]  C. P. Lee,et al.  A new strategy for prenatal diagnosis of homozygous alpha(0)-thalassemia. , 2006, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[13]  W. Piyamongkol,et al.  Prenatal eradication of Hb Bart's hydrops fetalis. , 2001, The Journal of reproductive medicine.